Screening of Liver Fibrosis Using APRI and FIB4 score in Individial With Diabetes Type 2 in Medicine Department of Sir Takhtsinhji Hospital Bhavnagar
Not Applicable
- Conditions
- Health Condition 1: E11- Type 2 diabetes mellitus
- Registration Number
- CTRI/2024/04/066241
- Lead Sponsor
- Priteshkumar Patel
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
All individuals with DM type 2 above the age of 18 years under Medicine Department, Sir T hospital for our study.
Exclusion Criteria
1.Secondary causes of fatty liver(Infective, Alcoholic, Genetic)
2.Hypothyroidism,CCF
3.Pregnant women
4.Individuals using/having used hepatotoxins (acetaminophen, methotrexate, nitrofurantoin, rifampicin & heavy metals).
5.Thrombocytopenia because of other causes
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To assess the association between APRI score and FIB4 score with Liver Fibrosis among Diabetes Type 2 patients in medicine department of Sir Takhtsinhji hospital BhavnagarTimepoint: 6 months
- Secondary Outcome Measures
Name Time Method 1.To assess age and gender wise distribution of liver fibrosis using same scoring system in DM type 2 patients. <br/ ><br>2.To establish the relation between duration of type 2 DM and liver fibrosis using different scoring system. <br/ ><br>3.To establish relation between obesity with type 2 DM and Liver fibrosis using different scoring system <br/ ><br>4.To compare the APRI score and FIB4 score for screening of liver fibrosis among T2DM patients in medicine department of Sir Takhtasinhji Hospital, Bhavnagar. <br/ ><br>5.To establish relation between USG Abdomen finding with Liver fibrosis using different scoring system <br/ ><br>in T2DM patientsTimepoint: 6 months